UPDATE: HSBC Upgrades Qiagen N.V. to Neutral

In a report issued Tuesday May 13th, HSBC upgraded the rating on Qiagen QGEN from Underweight to Neutral with a target price of €17.00. HSBC analyst Jan Keppeler anticipates Qiagen's better research budget funding should help the company hit the 2014 4-5 percent sales growth target. While Keppeler does not see Qiagen as a “bargain,” she does see the risk much more limited than previously anticipated. On the NASDAQ, shares of Qiagen last traded at $22.39, down about 0.5 percent despite the HSBC upgrade.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorNewsUpgradesPrice TargetAnalyst Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!